CLINIGMA ApS: Financial statements 2018
CVR: 39350580
Source: annual report 2018, Danish Business Authority
15/02/2018 – 31/12/2018
CLINIGMA ApS (CVR 39350580) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 61,871 and a net result of DKK 10,870. Equity in the 2018 report amounted to DKK 60,870. The solvency ratio was 18.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 61,871
- Profit/Loss
- DKK 10,870
- Equity
- DKK 60,870
- Total Assets
- DKK 332,236
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of February 15, 2018, Jens Harald Kongsø is registered as adm. dir. of CLINIGMA ApS.
CLINIGMA ApS was founded on February 15, 2018.
About CLINIGMA ApS
CLINIGMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2018. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named Clinical Survey Outcomes ApS. The management consists of Christian Bredmose Holm. The board consists of Rune Tarnø (chair) and Christian Bredmose Holm. The company is owned by Kongsø Gruppen ApS and CH Technologies Holding ApS. According to the 2025 annual report, the company had an average of 6 employees. In 2025, the company reported a gross profit of DKK 7,829,455 and a net result of DKK 2,200,115 compared with DKK -133,939 the year before. Equity in the 2025 report amounted to DKK 69.